Navigation Links
Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease
Date:7/16/2008

Raptor to Support Phase 2a Clinical Trial at UCSD

NOVATO, Calif., July 16 /PRNewswire-FirstCall/ -- Raptor Pharmaceuticals Corp. ("Raptor" or the "Company") (OTC Bulletin Board: RPTP), today announced the execution of a collaboration agreement (the "Agreement") with the University of California, San Diego ("UCSD") to include a Phase 2a clinical trial to evaluate a delayed-release preparation of cysteamine bitartrate ("Cysteamine") in adolescents diagnosed with Non-Alcoholic Steatohepatitis ("NASH"). NASH is a progressive form of liver disease that accounts for approximately 10% of newly diagnosed cases of chronic liver disease, and ranks as one of the leading causes of cirrhosis of the liver in the U.S.

Under the terms of the Agreement, clinical researchers from UCSD will perform the Phase 2a study at the University's General Clinical Research Center, and Raptor will provide funding and clinical supply of Cysteamine. In March 2008, Raptor acquired an exclusive, worldwide license to certain intellectual property and development rights from UCSD surrounding the use of Cysteamine as a potential treatment for NASH.

A rapid-release form of Cysteamine is currently approved for sale by the U.S. Food and Drug Administration ("FDA") for the treatment of nephropathic cystinosis, a rare, genetic lysosomal storage disease. Raptor is currently developing DR Cysteamine, a proprietary, delayed-release formulation of Cysteamine, designed to improve bioavailability and potentially reduce side effects associated with the presently marketed form.

Ted Daley, President of Raptor's clinical division stated, "We look forward to working with UCSD, one of the leading research universities in the nation, under this collaboration agreement. The University's clinical researchers have specific expertise in treating NASH patients, and have also worked extensively with Cysteamine. We are fortunate to work with this team to investigate our drug candidate
'/>"/>

SOURCE Raptor Pharmaceuticals Corp.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Raptor Pharmaceuticals Corp. Initiates Phase IIa Clinical Study for Convivia(TM)
2. Raptor Pharmaceuticals Provides Update of Product Programs
3. MAP Pharmaceuticals Announces Publication of MAP0004 Study in Current Medical Research and Opinion
4. Rib-X Pharmaceuticals Initiates Phase 2 Trial for RX-3341 In Complicated Skin and Skin Structure Infections
5. MAP Pharmaceuticals Initiates Phase 3 Clinical Trial in Patients With Migraine
6. VIA Pharmaceuticals Completes Patient Visits in Phase 2 Carotid Endarterectomy (CEA) Trial
7. Cerimon Pharmaceuticals Initiates Phase II Study to Evaluate Simulect(R) (Basiliximab) for Noninfectious Uveitis
8. Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis
9. Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV
10. University of Rochester Researcher Named Millennium Pharmaceuticals Career Development Scholar of The Leukemia & Lymphoma Society
11. Peregrine Pharmaceuticals Reports Positive Early Results in Phase II Study of Bavituximab in Breast Cancer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...e-FirstCall/ -- SCOLR Pharma, Inc. (Amex: DDD ) t...nine months ended September 30, 2009. ,, Step...aid, "We continue to advance discussions related t...eral potential partners have committed significant...es as they evaluate the potential commercial and/o...
(Date:11/6/2009)...wire-FirstCall/ -- DUSA Pharmaceuticals, Inc.(...is developing and marketing Levulan(®) Photod... patients with common skin conditions, announced t...er, will present a corporate overview at the Merri...ovember 10, 2009 at 10:00 a.m. ET at the Hotel Sof...
(Date:11/6/2009)...e/ -- Repossessions and liquidations of trucking e... 2009 declined as compared to similar figures from...rac Quarterly Index (NQI). The figures, culled fr...ssions and orderly liquidations, also indicated a ...inting equipment, offering mixed news on the healt...
Breaking Medicine Technology:SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 2SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 3SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 4SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 5SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 6SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 7SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 8SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 9NasTrac Quarterly Index Shows Decline in Trucking and Machine Tool Repossessions in Q3 2009 2NasTrac Quarterly Index Shows Decline in Trucking and Machine Tool Repossessions in Q3 2009 3NasTrac Quarterly Index Shows Decline in Trucking and Machine Tool Repossessions in Q3 2009 4GenVec Receives NASDAQ Notice of Minimum Bid Price Non Compliance 57333 1GenVec Receives NASDAQ Notice of Minimum Bid Price Non Compliance 57333 2GenVec Receives NASDAQ Notice of Minimum Bid Price Non Compliance 57333 3TriLink BioTechnologies Inc Relaunches Oligonucleotide Radiolabeling Services 14088 1TriLink BioTechnologies Inc Relaunches Oligonucleotide Radiolabeling Services 14088 2Shockwave Treatment May Not Be Best for Shoulder Pain 57330 1Shockwave Treatment May Not Be Best for Shoulder Pain 57330 2
... General,Hospital Vienna successfully completed it...reatment. The hospital is one of the first in the ...t option., (Logo: http://www.newscom.com/cgi-bin...vides a simultaneous control of the linear,acceler...le of the,multileaf collimator and dose rate. This...
... health, ROCKPORT, Maine, Feb. 12 The Maine Natu...eir patients to study the effects of,OmegaMaine(TM...um health., (Photo: http://www.newscom.com/cgi-b...rican Dental Association, 75% of all Americans wil...ich causes inflammation,bleeding, and swelling, an...
Other Medicine Technology:First Clinical Volumetric Modulated Arc Therapy Treatment Completed With Elekta Synergy(R) S at General Hospital Vienna 2First Clinical Volumetric Modulated Arc Therapy Treatment Completed With Elekta Synergy(R) S at General Hospital Vienna 3Maine Natural Health Company Conducts Dental Clinical Trial 2
(Date:11/8/2009)... Academy of Health holds open house at Victoria ca...s) November 8, 2009 -- UCW Academy of Health invit...umbia’s health care industry to attend their... 2009. , ,UCW Academy of Health, which offers dip... social services, designs its programs to meet the...
(Date:11/8/2009)...ng Taxes Nail Nation,s Job Creators ,, WASHINGT...to U.S. House passage of the health care bill (H.R...ncil (SBE Council) president & CEO Karen Kerri...o mistake, those voting for H.R. 3962 voted to bur...d crushing taxes and penalties. Even in the best o...
(Date:11/8/2009)...ewswire-USNewswire/ -- Tonight the House of Repres...erica Act, landmark health reform legislation that... affordable, stable and secure health care coverag...he insurance industry,s worst practices, would ext...eficit by $104 billion over ten years. Groups repr...
(Date:11/8/2009)...Global Solutions is pleased to announce that it ha... effort for ReSound who recently received an award...ct. The award includes not only the Veterans Admin...other federal agencies. , ...l Solutions is pleased to announce that it has bee...
(Date:11/8/2009)...’s Health Network (MHN) urges military veter...those linked to exposure to chemicals, atomic agen...r cancer is one of those cancers that is two times...once smoked or currently smoke cigarettes. , ... 8, 2009 -- Men’s Health Network (MHN) kicke...
Breaking Medicine News(10 mins):Health News:College Invites Public to Explore Career Options in Health Care 2Health News:Democratic National Committee Chairman Tim Kaine Issues Statement Praising the House of Representative's Historic Vote to Pass Health Insurance Reform 2Health News:Democratic National Committee Chairman Tim Kaine Issues Statement Praising the House of Representative's Historic Vote to Pass Health Insurance Reform 3Health News:3D Global Solutions Selected to Program Manage GN ReSound/VA Digital Hearing Aid Contract 2Health News:3D Global Solutions Selected to Program Manage GN ReSound/VA Digital Hearing Aid Contract 3Health News:Veterans' Day Reminder from Men's Health Network: Pay Attention to Bladder Cancer Symptoms and Risk Factors 2Health News:Veterans' Day Reminder from Men's Health Network: Pay Attention to Bladder Cancer Symptoms and Risk Factors 3
...enaged victim has recovered from the blackout , ...agers who fiendishly text their friends apparently...g and just plain incomprehensible to older generat...The ability to text if nothing else is medically ...
... ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA ), to...ull-year 2008 financial results on February 19, 20...se results and provide a pipeline update at 5:00 p...on.com, Domestic dial-in: 866-730-5766, Inte...
...arolina State University have successfully modifie...ecific cells inside the human body, without affect... each one thousands of times smaller than the widt...n, professor of chemistry, and Steven Lommel, prof...
...b. 12 Harris Corporation,(NYSE: HRS ), an inter...,company, has been awarded a ten-year contract by ...rofit healthcare system, to provide network,manage...ware and hardware support, 24/7 network operations...
...2 When an emergency squad pulls up to the home of..., chances are the paramedics have received a new b...developed by the University of Rochester Medical...oadable onto iPods or computers. The University ho...
... inherited condition resulting in blindness and cr...an affect both eye function and normal tooth devel...ted link between the formation of teeth and eyes h...ded by the Wellcome Trust and Yorkshire Eye Resear...
Other Medicine News:Health News:Texting After Fainting a Good Sign 2Health News:Texting After Fainting a Good Sign 3Health News:Nanoparticle 'smart bomb' targets drug delivery to cancer cells 2Health News:Health First Healthcare System Awards Harris Corporation Enterprise-wide Network Management and IT Services Contract 2Health News:Health First Healthcare System Awards Harris Corporation Enterprise-wide Network Management and IT Services Contract 3Health News:University of Rochester Launches iTraining for Emergency Responders 2Health News:Gaza strip families give first clue to condition causing blindness and tooth decay 2
Troponin I - Rapid Test
...or many patients with a diseased heart, the only t...t transplant. However, donor organs are not always...le die while they are on the waiting list for a do... devices (VAD) can save the life of a patient. On ...
...nstaTest AFP is an immunochromatographic in vitro ...n human serum. AFP is a protein with molecular mas...entration in serum is below 9 ng/mL; higher concen... testicular and presacral teratocarcinomas, and ot...
Roche/STAGO STA Compact
Medicine Products: